| The materials associated with these meetings are intended healthcare professionals and may refer to drug classes where Teva has a product and/or Teva products. This educational site for healthcare professionals has been initiated and funded by Teva. Prescribing information is available here. |
| Adverse events should be reported: Reporting forms and information can be found at www.mhra.gov.uk/yellowcard (UK) or www.hpra.ie (ROI). Adverse events should also be reported to Teva using the Reporting Side Effects Form or telephone +44 (0)207 540 7117, or email uk.safety@tevauk.com. |
On Demand Recordings
Head Start Annual Meeting
This video collection is from Head Start's Annual Meeting, held in June 2024
Exploring the current headache landscape- what do the new guidelines mean for patient practice?
Discuss what the new guidelines mean for patient practice with Dr Jane Anderson
Exploring predictors of response to anti-CGRP monoclonal antibodies: latest clinical evidence
Explore the latest clinical data with Professor Cristina Tassorelli
Behavioural change for migraine prevention
Professor Ivo Vlaev discusses the application of behavioural science in migraine prevention
Next event
Webinar - Thursday 12th December at 13:00
Join chair Dr Jessica Briscoe and speaker Dr Giorgio Lambru for an interactive discussion on psychiatric comorbidities associated with migraine. Sharing patient case studies on how CGRP inhibitors could help them.
Secure your place now by registering below and be at the forefront of optimising care
This webinar is organised and funded by Teva. Views provided by speakers are their own and not necessarily shared by Teva. Information at the meeting may discuss drug classes where Teva has a product. Prescribing information will be available at the meeting. The event is open to HCPs from the UK with an interest in headache and migraine.
Hear more from Teva
Keep up to date with upcoming webinars and events
Sign up Hear more from Teva
This educational site for healthcare professionals has been initiated and funded by Teva.
Registered in England No. 302461. Registered office: Teva UK Limited, Ridings Point, Whistler Drive, Castleford, West Yorkshire, WF10 5HX
+44 (0) 1977 628500 | www.tevauk.com | Copyright © 2024 Teva UK Limited
Adverse events should be reported: Reporting forms and information can be found at www.mhra.gov.uk/yellowcard (UK) or www.hpra.ie (ROI). Adverse events should also be reported to Teva using the Reporting Side Effects Form or telephone +44 (0) 207 540 7117, or email uk.safety@tevauk.com.
Privacy Policy | Pharmacovigilance Privacy Policy | Terms and Conditions | Accessibility | Reporting Adverse Events